Cargando…
Rate of All-cause Hospitalization at Year 2 Between Treatment Groups Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
BACKGROUND: The study compared rates of hospitalization between treatment groups in patients with nontuberculous mycobacterial lung disease (NTMLD) in a US national managed care claims database. METHODS: Patient (N = 1039) pharmacy claims at year 1 following NTMLD diagnosis were classified into 3 tr...
Autores principales: | Marras, Theodore, Mirsaeidi, Mehdi, Chou, Engels, Eagle, Gina, Zhang, Raymond, Wang, Ping, Zhang, Quanwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630781/ http://dx.doi.org/10.1093/ofid/ofx163.1801 |
Ejemplares similares
-
Healthcare Resource Utilization and Costs Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
por: Marras, Theodore, et al.
Publicado: (2017) -
122. All-Cause Mortality Increased With Nontuberculous Mycobacterial Lung Disease in US Medicare
por: Marras, Theodore, et al.
Publicado: (2018) -
Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States
por: Marras, Theodore K., et al.
Publicado: (2018) -
780. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare, 2008–2015
por: Winthrop, Kevin L, et al.
Publicado: (2018) -
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015
por: Winthrop, Kevin L., et al.
Publicado: (2020)